Stockreport

J&J beats first-quarter profit estimates on cancer drugs strength [Yahoo! Finance]

Alvotech  (ALVO) 
PDF Sales of its blockbuster psoriasis drug Stelara were flat at $2.45 billion in the first quarter, while sales of Darzalex jumped about 19% to $2.69 billion. Darzalex, [Read more]